MedTrace Logo

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

NCT00067158 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 585

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

nicotine transdermal system

Sponsors & Collaborators

  • New York University

    lead OTHER

Principal Investigators

  • Malcolm Reid, Ph.D. · New York University

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2004-07-31
Completion
2004-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00067158 on ClinicalTrials.gov